On June 12, 2025, Vimta Labs Ltd share price surged 4.56% to trade at ₹1,018.85 at 11:30 AM, gaining ₹44.45 over the previous close of ₹974.40. The stock opened at ₹992.95 and touched an intraday high of ₹1,028.85, while the low stood at ₹978.65.
The Volume Weighted Average Price (VWAP) for the session was ₹1,002.31. Vimta Labs currently trades within a 20% price band, with the upper limit set at ₹1,169.25 and the lower at ₹779.55. With this uptrend, the stock continues to trade closer to its 52-week high of ₹1,183.00,
The Hyderabad-based healthcare and research firm is set to issue bonus shares in a 1:1 ratio and has also declared a ₹2 per share dividend for the financial year 2024–25.
The company, with a market capitalisation of ₹2,168 crore as of June 12, 2025, informed stock exchanges that June 13, 2025, will be the record date for both entitlements.
In a significant move for its shareholders, Vimta Labs has announced its first-ever bonus issue. The bonus will be distributed in the ratio of 1:1, meaning eligible shareholders will receive one additional equity share for every fully paid-up equity share held.
This move is seen as an effort by the company to enhance liquidity and increase retail participation in its stock. According to the exchange filing, the bonus shares will carry a face value of ₹2 each.
In addition to the bonus shares, the board has recommended a final dividend of ₹2 per equity share of face value ₹2 each, further rewarding long-term investors. The record date for the same was May 30, 2025.
This dual action reflects Vimta Labs' strong financial performance and commitment to shareholder value creation.
Vimta Labs operates in the healthcare segment and specialises in contract research, testing, and analytical services. With increasing demand for quality research and diagnostics, the company has established a strong presence in both domestic and international markets.
Read More: Bonus, Stock Split and Dividend This Week June 9-13: Tata Elxsi, Adani Ports, VTM and More.
Vimta Labs' upcoming 1:1 bonus share issue, with a record date of June 13, 2025, marks a significant milestone in the company’s journey. The move is expected to enhance stock liquidity and attract broader investor participation, especially in the smallcap healthcare segment.
The recent price rally ahead of the record date reflects market optimism around this corporate action. As always, investors should conduct due diligence and align their decisions with personal financial goals before investing.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jun 12, 2025, 11:43 AM IST
Neha Dubey
Neha Dubey is a Content Analyst with 3 years of experience in financial journalism, having written for a leading newswire agency and multiple newspapers. At Angel One, she creates daily content on finance and the economy. Neha holds a degree in Economics and a Master’s in Journalism.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
